Curing the Incurable
NeuroCytonix is an emerging biomedical technology company founded in January 2017 to develop transformational medical technologies for regeneration of the nervous system.
REGROWING THE BRAIN
Currently we are conducting a double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of the NeuroCytotron in patients with cerebral palsy.
NeuroCytonix technology and its related protocols are a new approach to the treatment of non-progressive neurodegenerative diseases such as stroke, cerebral palsy and traumatic brain injury.
Our cutting-edge technology
neuron tissue engineering
NeuroCytonix has structured a team of 20 specialists in Monterrey, Mexico for cerebral palsy clinical trials.